AADI Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 37.30%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $19,965.60

Aadi Bioscience Insider Trading History Chart

Aadi Bioscience Share Price & Price History

^$2.24

▲ +0.06 (2.75%)

As of 12/3/2025 01:00 AM ET

Days: 30 | 90 | 365

Aadi Bioscience Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/3/2025	David James Lennon	CEO	Sell	5,690	$2.35	$13,371.50	33,429
3/3/2025	Scott M Giacobello	CFO	Sell	2,806	$2.35	$6,594.10	23,944
10/3/2024	David James Lennon	CEO	Sell	9,689	$1.94	$18,796.66	22,869
9/3/2024	Neil Desai	Chairman	Sell	40,000	$1.71	$68,400.00	1,171,543
8/5/2024	Neil Desai	Chairman	Sell	5,652	$1.34	$7,573.68	1,211,543
8/1/2024	Neil Desai	Chairman	Sell	15,415	$1.50	$23,122.50	1,236,128
7/1/2024	Neil Desai	Chairman	Sell	31,348	$1.45	$45,454.60	1,260,195
5/1/2024	Neil Desai	Chairman	Sell	40,000	$1.93	$77,200.00	1,331,543
4/1/2024	Neil Desai	Chairman	Sell	17,772	$2.31	$41,053.32	1,393,771
3/4/2024	Neil Desai	Chairman	Sell	14,964	$2.10	$31,424.40	1,411,543
3/1/2024	Neil Desai	Chairman	Sell	27,036	$1.97	$53,260.92	1,426,507
2/1/2024	Neil Desai	Chairman	Sell	42,000	$1.74	$73,080.00	1,453,543
1/2/2024	Neil Desai	Chairman	Sell	42,000	$2.06	$86,520.00	1,495,543
12/6/2023	Neil Desai	Chairman	Sell	7,037	$4.82	$33,918.34	1,537,543
12/4/2023	Neil Desai	Chairman	Sell	10,876	$5.15	$56,011.40	1,560,320
12/1/2023	Neil Desai	Chairman	Sell	8,347	$5.14	$42,903.58	1,571,196
11/1/2023	Neil Desai	Chairman	Sell	10,338	$4.32	$44,660.16	1,611,205
10/2/2023	Neil Desai	Chairman	Sell	25,569	$4.37	$111,736.53	1,637,974
9/5/2023	Neil Desai	Chairman	Sell	21,000	$5.63	$118,230.00	1,670,654
9/1/2023	Neil Desai	Chairman	Sell	13,889	$5.97	$82,917.33	1,691,654
8/1/2023	Neil Desai	Chairman	Sell	22,710	$5.22	$118,546.20	1,724,833
7/5/2023	Neil Desai	Chairman	Sell	16,171	$6.55	$105,920.05	1,763,372
7/3/2023	Neil Desai	Chairman	Sell	10,000	$6.64	$66,400.00	1,779,543
6/5/2023	Neil Desai	Chairman	Sell	17,315	$8.11	$140,424.65	1,796,803
6/1/2023	Neil Desai	Chairman	Sell	4,982	$7.92	$39,457.44	1,826,561
5/3/2023	Neil Desai	Chairman	Sell	7,695	$7.68	$59,097.60	1,833,848
5/1/2023	Neil Desai	Chairman	Sell	24,479	$7.80	$190,936.20	1,849,064
4/5/2023	Neil Desai	Chairman	Sell	7,336	$7.24	$53,112.64	1,885,755
4/3/2023	Neil Desai	Chairman	Sell	9,583	$7.45	$71,393.35	1,905,960

SEC Filings (Institutional Ownership Changes) for Aadi Bioscience (NASDAQ:AADI)

52.08% of Aadi Bioscience stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Aadi Bioscience Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/17/2025	Two Sigma Investments LP	68,555	$0.22M	0.0%	+305.2%	0.278%
2/17/2025	Two Sigma Advisers LP	61,686	$0.20M	0.0%	+95.2%	0.250%
2/17/2025	Bridgeway Capital Management LLC	115,400	$0.36M	0.0%	+23.7%	0.467%
2/17/2025	Ally Bridge Group NY LLC	817,939	$2.58M	2.2%	N/A	3.311%
2/17/2025	Acorn Capital Advisors LLC	1,147,052	$3.62M	2.0%	N/A	4.644%
2/14/2025	Northern Trust Corp	91,151	$0.29M	0.0%	+33.1%	0.369%
2/14/2025	QVT Financial LP	2,313,702	$7.30M	0.6%	N/A	9.367%
2/13/2025	Renaissance Technologies LLC	456,022	$1.44M	0.0%	-1.3%	1.846%
2/12/2025	Geode Capital Management LLC	217,294	$0.69M	0.0%	+4.1%	0.880%
2/7/2025	BML Capital Management LLC	2,100,000	$6.63M	4.1%	+5.0%	8.519%
1/29/2025	Peapod Lane Capital LLC	442,942	$1.40M	1.4%	N/A	1.797%
11/15/2024	XTX Topco Ltd	15,591	$32K	0.0%	N/A	0.063%
11/15/2024	Jane Street Group LLC	25,989	$54K	0.0%	-80.6%	0.105%
11/15/2024	Point72 Asia Singapore Pte. Ltd.	12,121	$25K	0.0%	-51.9%	0.049%
11/5/2024	BML Capital Management LLC	2,000,000	$4.12M	2.4%	N/A	8.127%
11/5/2024	GSA Capital Partners LLP	21,097	$43K	0.0%	-23.3%	0.086%
9/16/2024	Point72 Asia Singapore Pte. Ltd.	25,176	$37K	0.0%	N/A	0.103%
8/15/2024	Point72 Asia Singapore Pte. Ltd.	25,176	$37K	0.0%	N/A	0.103%
8/9/2024	Renaissance Technologies LLC	439,222	$0.64M	0.0%	-19.2%	1.789%
8/5/2024	Acuitas Investments LLC	352,483	$0.52M	0.3%	+10.8%	1.436%
5/7/2024	Marquette Asset Management LLC	57,807	$0.14M	0.0%	N/A	0.235%
2/12/2024	Decheng Capital LLC	526,329	$1.06M	0.3%	N/A	2.146%
10/27/2023	TD Asset Management Inc	48,166	$0.23M	0.0%	+100.0%	0.196%
8/21/2023	Affinity Asset Advisors LLC	187,675	$1.28M	0.4%	N/A	0.765%
8/14/2023	Prelude Capital Management LLC	11,074	$76K	0.0%	N/A	0.045%
8/11/2023	ExodusPoint Capital Management LP	136,511	$0.93M	0.0%	+34.1%	0.559%
8/2/2023	Bank of Montreal Can	22,572	$0.19M	0.0%	N/A	0.092%
5/16/2023	BVF Inc. IL	318,205	$2.30M	0.1%	-43.4%	1.302%
5/15/2023	Ghost Tree Capital LLC	150,000	$1.09M	0.3%	+66.7%	0.614%
5/11/2023	ExodusPoint Capital Management LP	101,835	$0.74M	0.0%	+35.2%	0.417%
5/11/2023	Knott David M Jr	183,688	$1.33M	0.5%	+574.3%	0.752%
5/3/2023	Jump Financial LLC	20,300	$0.15M	0.0%	+91.5%	0.083%
3/23/2023	MetLife Investment Management LLC	7,671	$98K	0.0%	N/A	0.031%
2/15/2023	Alerce Investment Management L.P.	1,630,830	$20.92M	24.1%	+26.0%	6.684%
2/13/2023	Knott David M Jr	27,242	$0.35M	0.1%	-44.4%	0.112%
2/10/2023	Opaleye Management Inc.	252,046	$3.23M	1.1%	N/A	1.033%
11/14/2022	Point72 Asset Management L.P.	567,129	$8.01M	0.0%	+4.6%	2.325%
11/14/2022	RA Capital Management L.P.	590,218	$8.34M	0.2%	+54.1%	2.419%
11/14/2022	Ghost Tree Capital LLC	200,000	$2.83M	0.8%	+33.3%	0.820%
11/10/2022	ExodusPoint Capital Management LP	57,530	$0.81M	0.0%	+39.8%	0.236%
11/7/2022	Jump Financial LLC	19,300	$0.27M	0.0%	N/A	0.079%
10/27/2022	Strs Ohio	2,500	$35K	0.0%	-26.5%	0.012%
8/15/2022	Point72 Asset Management L.P.	542,044	$6.68M	0.0%	+156.2%	2.588%
8/15/2022	Vivo Capital LLC	509,572	$6.28M	0.6%	-34.0%	2.433%
8/12/2022	Ikarian Capital LLC	412,343	$1.27M	0.2%	+97.9%	1.969%
8/12/2022	Rafferty Asset Management LLC	17,839	$0.22M	0.0%	-56.2%	0.085%
8/11/2022	Knott David M Jr	14,039	$0.17M	0.1%	N/A	0.067%
8/11/2022	Alps Advisors Inc.	12,423	$0.15M	0.0%	-42.1%	0.059%
8/4/2022	TD Asset Management Inc.	24,083	$0.30M	0.0%	-30.8%	0.115%
7/25/2022	Strs Ohio	3,400	$41K	0.0%	N/A	0.016%
7/6/2022	Neville Rodie & Shaw Inc.	13,333	$0.16M	0.0%	N/A	0.064%
5/16/2022	Eversept Partners LP	150,817	$2.56M	0.2%	N/A	0.720%
5/16/2022	Ghost Tree Capital LLC	150,000	$2.55M	0.6%	-25.0%	0.716%
5/10/2022	Decheng Capital Management III Cayman LLC	526,329	$8.93M	2.7%	N/A	2.513%
5/9/2022	Qube Research & Technologies Ltd	17,333	$0.29M	0.0%	N/A	0.083%
4/26/2022	Sciencast Management LP	11,513	$0.20M	0.0%	N/A	0.055%
2/16/2022	Ghost Tree Capital LLC	200,000	$4.83M	1.7%	N/A	0.957%
2/15/2022	683 Capital Management LLC	18,025	$0.44M	0.0%	N/A	0.086%
2/11/2022	Renaissance Technologies LLC	128,522	$3.10M	0.0%	-22.4%	0.615%
2/10/2022	Rafferty Asset Management LLC	27,967	$0.68M	0.0%	N/A	0.134%
2/10/2022	Citigroup Inc.	36,166	$0.87M	0.0%	+5,481.2%	0.173%
2/10/2022	TD Asset Management Inc.	34,783	$0.84M	0.0%	N/A	0.166%
2/9/2022	Alps Advisors Inc.	24,174	$0.58M	0.0%	N/A	0.116%
2/8/2022	Northern Trust Corp	36,808	$0.89M	0.0%	N/A	0.176%
1/27/2022	Ascent Wealth Partners LLC	10,000	$0.24M	0.0%	N/A	0.048%
11/16/2021	Opaleye Management Inc.	45,020	$1.32M	0.2%	N/A	1.416%
11/16/2021	VR Adviser LLC	1,529,402	$44.92M	5.8%	N/A	48.110%
11/16/2021	BVF Inc. IL	1,147,052	$33.69M	1.3%	N/A	36.082%
11/15/2021	RTW Investments LP	764,701	$21.34M	0.3%	N/A	24.055%
11/15/2021	Rock Springs Capital Management LP	764,701	$22.46M	0.5%	N/A	24.055%
11/15/2021	RA Capital Management L.P.	347,668	$10.21M	0.1%	N/A	10.936%
11/12/2021	Renaissance Technologies LLC	165,655	$4.87M	0.0%	N/A	5.211%
11/10/2021	US Bancorp DE	3,333	$98K	0.0%	N/A	0.105%
11/9/2021	BlackRock Inc.	16,250	$0.48M	0.0%	N/A	0.511%
11/2/2021	Parallel Advisors LLC	6,408	$0.19M	0.0%	N/A	0.202%
8/16/2021	State Street Corp	127,850	$0.22M	0.0%	N/A	0.268%

Data available starting January 2016

Aadi Bioscience, Inc., a biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug product candidate comprises FYARRO, a form of sirolimus protein-bound particles for injectable suspension for the treatment in adult patients with advanced unresectable or metastatic malignant PEComa. The company is also involved in evaluating FYARRO in cancers, including indications targeting specific genomic alterations that activate the mTOR pathway. Aadi Bioscience, Inc. was incorporated in 2007 and is headquartered in Pacific Palisades, California.

Today's Range

Now: $2.24

$2.18

$2.29

50 Day Range

MA: $2.19

$1.89

$2.66

52 Week Range

Now: $2.24

$1.21

$3.81

Volume

107,993 shs

Average Volume

261,100 shs

Market Capitalization

$55.32 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.68

Who are the company insiders with the largest holdings of Aadi Bioscience?: Aadi Bioscience's top insider investors include:
Neil Desai (Chairman)
David James Lennon (CEO)
Scott M Giacobello (CFO)
Learn More about top insider investors at Aadi Bioscience.